On March 9, 2023, Apeiron Investment Group Ltd announced that it delivered a letter to Sensei Biotherapeutics, Inc nominating a slate of 3 qualified candidates, including Peter Miles Davies, Lorin Van Nuland, and Matthew N. Shenkman for election to the Company?s Board of Directors at the Company?s 2023 annual meeting of stockholders. In addition, Apeiron Investment believes that the nominees have the qualifications, experience and skill sets necessary to serve as directors of the Company, as evidenced by their biographies.